The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: The clinical guidelines. DOI Creative Commons
Konstantinos Ν. Fountoulakis, Heinz Grunze, Eduard Vieta

и другие.

The International Journal of Neuropsychopharmacology, Год журнала: 2016, Номер unknown, С. pyw109 - pyw109

Опубликована: Ноя. 29, 2016

The current paper introduces the actual International College of Neuro-Psychopharmacology clinical guidelines for treatment bipolar disorder.

Язык: Английский

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease DOI Creative Commons
Paul E. Stevens, Sofia B. Ahmed, Juan Jesús Carrero

и другие.

Kidney International, Год журнала: 2024, Номер 105(4), С. S117 - S314

Опубликована: Март 13, 2024

This article is published as part of a supplement sponsored by Kidney Disease: Improving Global Outcomes (KDIGO). The opinions or views expressed in this are those the authors and do not necessarily reflect recommendations International Society Nephrology Elsevier. Dosages, indications, methods use for products that referred to may their clinical experience be derived from professional literature other sources.

Язык: Английский

Процитировано

1936

Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology DOI Open Access

GM Goodwin,

Peter Haddad, I. Nicol Ferrier

и другие.

Journal of Psychopharmacology, Год журнала: 2016, Номер 30(6), С. 495 - 553

Опубликована: Март 15, 2016

The British Association for Psychopharmacology guidelines specify the scope and target of treatment bipolar disorder. second version, like first, is based explicitly on available evidence presented, previous Clinical Practice guidelines, as recommendations to aid clinical decision making practitioners: they may also serve a source information patients carers. are presented together with more detailed but selective qualitative review evidence. A consensus meeting, involving experts in disorder its treatment, reviewed key areas considered strength implications. were drawn up after extensive feedback from participants interested parties. supporting was rated. cover diagnosis disorder, management, strategies use medicines episodes, relapse prevention stopping treatment.

Язык: Английский

Процитировано

1203

Handbook of Religion and Health DOI
Harold G. Koenig, Tyler J. VanderWeele, John R. Peteet

и другие.

Oxford University Press eBooks, Год журнала: 2023, Номер unknown

Опубликована: Ноя. 23, 2023

Abstract The 2001 (first) edition of this Handbook was a comprehensive review history, research, and discussions on religion health through the year 2000. Appendix listed 1,200 separate quantitative studies each rated in quality 0–10 scale, followed by about 2,000 references an extensive index for rapid topic identification. 2012 (second) systematically updated research from 2000 to 2010, with number then reaching thousands. This 2023 (third) is most scientifically rigorous date, covering best published 2021 emphasis prospective randomized controlled trials. Beginning Foreword Dr. Howard K. Koh, former US Assistant Secretary Health Department Human Services, nearly 600,000-word volume examines almost every aspect health, reviewing past more recent relationship between outcomes. Furthermore, all its 34 chapters conclude clinical community applications, making text relevant both healthcare professionals (physicians, nurses, social workers, rehabilitation therapists, counselors, psychologists, sociologists, etc.) clergy (community clergy, chaplains, pastoral etc.). book’s focuses studies, describing study single line, allowing researchers quickly locate existing research. It should not be surprising that two decades has been cited health.

Язык: Английский

Процитировано

1056

Mental health in elite athletes: International Olympic Committee consensus statement (2019) DOI Open Access
Claudia L. Reardon, Brian Hainline, Cindy Miller Aron

и другие.

British Journal of Sports Medicine, Год журнала: 2019, Номер 53(11), С. 667 - 699

Опубликована: Май 16, 2019

Mental health symptoms and disorders are common among elite athletes, may have sport related manifestations within this population impair performance. cannot be separated from physical health, as evidenced by mental increasing the risk of injury delaying subsequent recovery. There no evidence or consensus based guidelines for diagnosis management in athletes. Diagnosis must differentiate character traits particular to athletes psychosocial maladaptations.Management strategies should address all contributors consider biopsychosocial factors relevant maximise benefit minimise harm. Management involve both treatment affected individual optimising environments which train compete. To advance a more standardised, approach an International Olympic Committee Consensus Work Group critically evaluated current state science provided recommendations.

Язык: Английский

Процитировано

869

Treatment of bipolar disorder DOI
John Geddes, David J. Miklowitz

The Lancet, Год журнала: 2013, Номер 381(9878), С. 1672 - 1682

Опубликована: Май 1, 2013

Язык: Английский

Процитировано

730

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders DOI
Gin S. Malhi,

Darryl Bassett,

Philip Boyce

и другие.

Australian & New Zealand Journal of Psychiatry, Год журнала: 2015, Номер 49(12), С. 1087 - 1206

Опубликована: Дек. 1, 2015

Objectives: To provide guidance for the management of mood disorders, based on scientific evidence supplemented by expert clinical consensus and formulate recommendations to maximise salience utility. Methods: Articles information sourced from search engines including PubMed EMBASE, MEDLINE, PsycINFO Google Scholar were literature known disorders committee (MDC) (e.g., books, book chapters government reports) published depression bipolar disorder guidelines. Information was reviewed discussed members MDC findings then formulated into consensus-based guidance. The guidelines subjected rigorous successive consultation external review involving: advisors, public, key stakeholders, professional bodies specialist groups with interest in disorders. Results: Royal Australian New Zealand College Psychiatrists practice (Mood Disorders CPG) up-to-date advice regarding that is informed experience. Mood CPG intended use psychiatrists, psychologists, physicians others an mental health care. Conclusions: Disorder first Clinical Practice Guideline address both depressive It provides within evidence-based framework, consensus. Committee: Professor Gin Malhi (Chair), Darryl Bassett, Philip Boyce, Richard Bryant, Paul Fitzgerald, Dr Kristina Fritz, Malcolm Hopwood, Bill Lyndon, Roger Mulder, Greg Murray, Porter Associate Ajeet Singh. International advisors: Carlo Altamura, Francesco Colom, Mark George, Guy Goodwin, McIntyre, Ng, John O’Brien, Harold Sackeim, Jan Scott, Nobuhiro Sugiyama, Eduard Vieta, Lakshmi Yatham. Marie-Paule Austin, Michael Berk, Yulisha Byrow, Helen Christensen, Nick De Felice, A/Professor Seetal Dodd, Megan Galbally, Josh Geffen, Hazell, David Horgan, Felice Jacka, Gordon Johnson, Anthony Jorm, Jon-Paul Khoo, Jayashri Kulkarni, Cameron Lacey, Noeline Latt, Florence Levy, Andrew Lewis, Colleen Loo, Thomas Mayze, Linton Meagher, Mitchell, Daniel O’Connor, Tim Outhred, Rowe, Narelle Shadbolt, Martien Snellen, Tiller, Watkins, Raymond Wu.

Язык: Английский

Процитировано

730

The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders DOI
Isabella Pacchiarotti, David J. Bond, Ross J. Baldessarini

и другие.

American Journal of Psychiatry, Год журнала: 2013, Номер 170(11), С. 1249 - 1262

Опубликована: Сен. 13, 2013

The risk-benefit profile of antidepressant medications in bipolar disorder is controversial. When conclusive evidence lacking, expert consensus can guide treatment decisions. International Society for Bipolar Disorders (ISBD) convened a task force to seek recommendations on the use antidepressants disorders.An iteratively developed through serial consensus-based revisions using Delphi method. Initial survey items were based systematic review literature. Subsequent surveys included new or reworded and that needed be rerated. This process resulted final ISBD Task Force clinical disorder.There striking incongruity between wide weak base efficacy safety drugs disorder. Few well-designed, long-term trials prophylactic benefits have been conducted, there insufficient with combined mood stabilizers. A major concern risk switch hypomania, mania, mixed states. Integrating experience members, was reached 12 statements disorder.Because limited data, could not make broad endorsing but acknowledged individual patients may benefit from antidepressants. Regarding safety, serotonin reuptake inhibitors bupropion lower rates manic than tricyclic tetracyclic norepinephrine-serotonin inhibitors. frequency severity antidepressant-associated elevations appear greater I II Hence, should prescribed only as an adjunct mood-stabilizing medications.

Язык: Английский

Процитировано

685

Bipolar disorders DOI
Roger S. McIntyre, Michael Berk, Elisa Brietzke

и другие.

The Lancet, Год журнала: 2020, Номер 396(10265), С. 1841 - 1856

Опубликована: Дек. 1, 2020

Язык: Английский

Процитировано

678

Bipolar disorders DOI
Eduard Vieta, Michael Berk, Thomas G. Schulze

и другие.

Nature Reviews Disease Primers, Год журнала: 2018, Номер 4(1)

Опубликована: Март 7, 2018

Язык: Английский

Процитировано

648

Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis DOI
Andrea Cipriani, Corrado Barbui, Georgia Salanti

и другие.

The Lancet, Год журнала: 2011, Номер 378(9799), С. 1306 - 1315

Опубликована: Авг. 17, 2011

Язык: Английский

Процитировано

608